Skip Navigation

Staff Detail

Skip sharing on social media links


Hazra, Rohan

Formal Title:






Bethesda ,MD 20817

Topics in my portfolio:


Dr. Rohan Hazra is the chief of the Maternal and Pediatric Infectious Disease Branch at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH). He joined the NICHD in 2007, and has overseen the Pediatric HIV AIDS Cohort Study (PHACS), a multicenter United States-based program that follows both perinatally HIV-infected youth and HIV-exposed/uninfected infants, children, and youth since 2008.  In addition, he is actively involved in pediatric HIV clinical trials and other observational studies in the United States and globally. 

He received his B.S. degree in biology from Yale University and his M.D. from the Johns Hopkins University School of Medicine. Following graduation from medical school, he completed a pediatric residency and pediatric infectious disease fellowship at Children's Hospital in Boston. Prior to joining NICHD he conducted clinical studies in pediatric HIV in the National Cancer Institute’s intramural program, where he continues to have an adjunct position. He is certified by the American Board of Pediatrics in both pediatrics and pediatric infectious diseases.


Publications (PubMed):

Biomarkers and neurodevelopment in perinatally HIV-infected or exposed youth: a structural equation model analysis.
Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youth treated with tenofovir disoproxil fumarate.
Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment.
Association of higher plasma vitamin d binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?
The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents.
Insulin resistance and glucose and lipid concentrations in a cohort of perinatally HIV-infected Latin American children.
Tenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infection.
Preexposure prophylaxis for adolescents and young adults at risk for HIV infection: is an ounce of prevention worth a pound of cure?
Combination antiretroviral use and preterm birth.
Bone mineral density in children and adolescents with perinatal HIV infection.
Congenital Anomalies and In Utero Antiretroviral Exposure in Human Immunodeficiency Virus-Exposed Uninfected Infants.
Safety of In Utero and Neonatal Antiretroviral Exposure: Cognitive and Academic Outcomes in HIV-exposed, Uninfected Children 5-13 Years of Age.
Increased Coronary Vessel Wall Thickness in HIV-Infected Young Adults.
BOND National Institues of Health Home Home Division of Intramural Population Health Research